Yusen Logistics Benelux Belgium Keetberglaan Pharmaceutical Import Profile — Belgium (DGFT 2022–2026)

Name: Yusen Logistics Benelux Belgium Keetberglaan Pharmaceutical Import Records from India — 7 Products, $9.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Yusen Logistics Benelux Belgium Keetberglaan — Pharmaceutical Importer Profile (2026) | 7 Products, $9.1M Trade | TransData Nexus

Yusen Logistics Benelux Belgium Keetberglaan

Pharmaceutical Importer · Belgium · Medical Devices & Diagnostics Focus · $9.1M Total Trade · DGFT Verified

Yusen Logistics Benelux Belgium Keetberglaan is a pharmaceutical importer based in Belgium with a total trade value of $9.1M across 7 products in 5 therapeutic categories. Based on 198 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Yusen Logistics Benelux Belgium Keetberglaan sources from 1 verified Indian supplier, with Sun Pharmaceutical Industries Limited accounting for 100.0% of imports.

Yusen Logistics Benelux Belgium Keetberglaan — Import Portfolio & Supplier Network

Yusen Logistics Benelux Belgium Keetberglaan import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Yusen Logistics Benelux Belgium Keetberglaan?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sun Pharmaceutical Industries Limited	$17.0M	617	100.0%

Yusen Logistics Benelux Belgium Keetberglaan sources from 1 verified Indian supplier across 582 distinct formulations. The sourcing is highly concentrated — Sun Pharmaceutical Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Tobramycin sun 300MG/5ML Nebulizer solution tobramycin 300MG/5ML nebuliser solution [351 Pack x 4 x 14 = 19656	$269.7K	6
Tobramycin sun 300MG/5ML Nebulizer solution tobramycin 300MG/5ML nebuliser solution [475 Pack x 4 x 14 = 26600	$150.0K	3
Melphalan sun injection 50MG melphalanhydrochloride 50MG powder for solution for infusion [Pack: 1	$109.2K	3
Contiflo xl capsules 0.4MG Pack : box3x10s batch : dfe1388a dfe1420a dfe2206aeach prolonged release cap	$100.0K	2
Cefaclor terapia sus 250MG/5ML Pack: 75ML bottl batch: dfe2084a dfe2085a when constituted as directed Each 5ML of the	$100.0K	2
Serlift TAB 100MG Pack : Box 2x14s batch: dfe5063a, dfe5064a Each film coated TAB conts: sertraline hcl eq to	$100.0K	2
Clopidogrel bisulphate tablets 75MG clopidogrel terapia TAB 75MG batch no. as per attached	$100.0K	2
Medabon TAB 200/0.2MG 5btl gb Pack : 5'sbottle batch details as per document 244 shippers on 12	$100.0K	2
Fyremadel INJ 0.25MG/0.5ML 1's pfs de Pack : 01*01 batch details as per	$100.0K	2
Tobramycin sun 300MG/5ML Nebulizer solution tobramycin 300MG/5ML nebuliser solution [313 Pack x 4 x 14 = 17528	$98.1K	3
Cefaclor basics ts sus 250MG/5ML Pack: 100ML bott batch: dfe2307a dfe2645a whenconstituted as directed Each 5ML of	$91.5K	2
Tobramycin sun 300MG/5ML Nebulizer solution tobramycin 300MG/5ML nebuliser solution [73 Pack x 4 x 14 = 4088	$78.0K	3
Esomeprazolo INJ 40MG 1's vl it esomeprazole sodium for injection 40 MG/vialpack : 1 vial batch details as per	$58.9K	2
Tamsulosin basics-r cap mr 0.4MG Pack :box5x20s batch : dfe2310b dfe2346c eachcap conts: tamsulosin hcl 0.4MG	$50.0K	1
Aciclovir tablets BP 200MG aciclovir TAB 200MG Pack : box5x5s batch : dfe1152c dfe1189a Each uncoated TAB conts	$50.0K	1

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Strip	Medical Devices & Diagnostics	$3.4M	68	1.7%	7
2	Sertraline	CNS & Psychiatric	$2.5M	51	0.5%	13
3	Clarithromycin	Antibiotics	$1.3M	27	1.3%	11
4	Tobramycin	Antibiotics	$750.0K	15	1.9%	11
5	Temozolomide	Advanced Oncology	$536.7K	23	2.3%	8
6	Imipenem	Advanced Antibiotics	$350.0K	7	1.0%	9
7	Melphalan	Advanced Oncology	$216.3K	7	1.7%	10

Yusen Logistics Benelux Belgium Keetberglaan imports 7 pharmaceutical products across 5 categories into Belgium totaling $9.1M.

Yusen Logistics Benelux Belgium Keetberglaan — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Yusen Logistics Benelux Belgium Keetberglaan is a subsidiary of Yusen Logistics Benelux, a global logistics provider with over 60 years of expertise in freight forwarding and transportation. The company is headquartered at Keetberglaan 2, 9120 Melsele, Belgium. (craft.co) Yusen Logistics Benelux offers a comprehensive range of services, including air and ocean freight, contract logistics, and origin cargo management, serving industries such as automotive, aerospace, retail, healthcare, technology, and food. (craft.co)

In Belgium, Yusen Logistics Benelux plays a significant role in the pharmaceutical distribution network. The Keetberglaan facility in Melsele serves as a key hub for the importation and distribution of pharmaceutical products, particularly those sourced from India. This strategic location enables efficient logistics operations, ensuring timely delivery of pharmaceutical goods to various stakeholders within the Belgian healthcare sector.

2Distribution Network

Yusen Logistics Benelux operates a robust distribution network across Belgium, with multiple facilities strategically located to optimize logistics operations. The Keetberglaan facility in Melsele serves as a central hub for pharmaceutical imports, facilitating efficient storage and distribution processes. Additional facilities in Beveren, Herentals, and Machelen further enhance the company's ability to serve diverse regions within Belgium. (craft.co)

The company's logistics capabilities are bolstered by its global presence, with over 400 offices worldwide. This extensive network enables Yusen Logistics Benelux to manage complex supply chains effectively, ensuring timely and reliable delivery of pharmaceutical products both within Belgium and to international markets.

3Industry Role

Yusen Logistics Benelux Belgium Keetberglaan functions primarily as a logistics intermediary within Belgium's pharmaceutical supply chain. While it imports pharmaceutical products, including finished formulations from India, it does not engage directly in wholesaling or parallel importing. Instead, the company focuses on the efficient storage, handling, and distribution of these products to various stakeholders in the Belgian healthcare sector. This role is crucial in ensuring that pharmaceutical goods reach their intended destinations promptly and in compliance with regulatory standards.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Yusen Logistics Benelux Belgium Keetberglaan

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Yusen Logistics Benelux Belgium Keetberglaan demonstrates a high degree of sourcing concentration, with a total import value of $9.1 million USD from India, accounting for 198 shipments. All pharmaceutical imports are sourced from a single supplier, Sun Pharmaceutical Industries Limited, indicating a strategic choice to maintain a focused and streamlined supply chain. This approach may offer benefits such as simplified logistics and potentially better terms due to the volume of business.

However, this single-source dependency also introduces risks, particularly in scenarios where supply disruptions occur. The absence of alternative suppliers could lead to challenges in maintaining consistent product availability. The shipment data reveals a consistent pattern of imports, suggesting a stable and reliable relationship with the supplier. Nonetheless, it is advisable for Yusen Logistics Benelux to consider diversifying its supplier base to mitigate potential risks associated with over-reliance on a single source.

2Supply Chain Resilience

The resilience of Yusen Logistics Benelux Belgium Keetberglaan's Indian supply chain is closely tied to its exclusive partnership with Sun Pharmaceutical Industries Limited. While this relationship ensures consistency in product quality and supply, the lack of backup suppliers poses a vulnerability. In the event of disruptions—such as production issues, regulatory challenges, or logistical constraints—there are limited options to source alternative products.

Importing Pharmaceuticals into Belgium — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Belgium

1Regulatory Authority & Framework

In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. FAMHP ensures that all pharmaceutical imports comply with the European Union's stringent regulations, including the EU Directive 2001/83/EC, which governs the Community code relating to medicinal products for human use.

For Indian pharmaceutical products to be marketed in Belgium, they must undergo a centralized marketing authorization process through the European Medicines Agency (EMA). This process evaluates the safety, efficacy, and quality of the products, ensuring they meet EU standards. Once authorized, the products are listed in the European Union Register of Medicinal Products, allowing them to be marketed across EU member states, including Belgium.

2Import Licensing & GMP

Import licensing in Belgium requires that pharmaceutical products are accompanied by a valid marketing authorization issued by the EMA. Additionally, the products must be manufactured in facilities that comply with Good Manufacturing Practice (GMP) standards recognized by the EU, WHO, or PIC/S. Yusen Logistics Benelux, as a logistics intermediary, must ensure that all imported pharmaceutical products meet these regulatory requirements to facilitate smooth customs clearance and distribution within Belgium.

Yusen Logistics Benelux Belgium Keetberglaan — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Yusen Logistics Benelux Belgium Keetberglaan's focus on importing pharmaceutical products from India, particularly in the categories of Medical Devices & Diagnostics, CNS & Psychiatric, and Antibiotics, aligns with market demand in Belgium. The Medical Devices & Diagnostics category accounts for 37.3% of imports, CNS & Psychiatric for 28.0%, and Antibiotics for 22.5%. This strategic selection reflects the company's commitment to addressing critical healthcare needs and providing essential treatments to the Belgian population.

The emphasis on these therapeutic areas is driven by the high prevalence of conditions requiring medical devices, psychiatric care, and antibiotic treatments in Belgium. By focusing on these segments, Yusen Logistics Benelux ensures a steady supply of vital pharmaceutical products, contributing to the overall health and well-being of the community.

2Sourcing Profile

Yusen Logistics Benelux Belgium Keetberglaan's sourcing strategy is centered on importing finished pharmaceutical formulations from India, with a particular focus on generic drugs. The company's portfolio includes a diverse range of 582 unique formulations, indicating a broad approach to meeting the varied needs of the Belgian pharmaceutical market. India's well-established pharmaceutical industry, known for its adherence to international quality standards, makes it a reliable source for these products.

This sourcing strategy allows Yusen Logistics Benelux to offer a wide array of pharmaceutical products, ensuring that healthcare providers in Belgium have access to essential medications at competitive prices. The focus on finished formulations also simplifies the supply chain, reducing the complexities associated with sourcing raw materials or active pharmaceutical ingredients.

Frequently Asked Questions — Yusen Logistics Benelux Belgium Keetberglaan

What products does Yusen Logistics Benelux Belgium Keetberglaan import from India?

Yusen Logistics Benelux Belgium Keetberglaan imports 7 pharmaceutical products across 5 categories. Top imports: Strip ($3.4M), Sertraline ($2.5M), Clarithromycin ($1.3M), Tobramycin ($750.0K), Temozolomide ($536.7K).

Who supplies pharmaceuticals to Yusen Logistics Benelux Belgium Keetberglaan from India?

Yusen Logistics Benelux Belgium Keetberglaan sources from 1 verified Indian suppliers. The primary supplier is Sun Pharmaceutical Industries Limited (100.0% of imports, $17.0M).

What is Yusen Logistics Benelux Belgium Keetberglaan's total pharmaceutical import value?

Yusen Logistics Benelux Belgium Keetberglaan's total pharmaceutical import value from India is $9.1M, based on 198 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Yusen Logistics Benelux Belgium Keetberglaan focus on?

Yusen Logistics Benelux Belgium Keetberglaan imports across 5 categories. The largest: Medical Devices & Diagnostics (37.3%), CNS & Psychiatric (28.0%), Antibiotics (22.5%).

Get Full Yusen Logistics Benelux Belgium Keetberglaan Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Yusen Logistics Benelux Belgium Keetberglaan

Yusen Logistics Benelux Belgium Keetberglaan — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Yusen Logistics Benelux Belgium Keetberglaan?

What Formulations Does Yusen Logistics Benelux Belgium Keetberglaan Import?

What Products Does Yusen Logistics Benelux Belgium Keetberglaan Import?

Top Products by Import Value

Yusen Logistics Benelux Belgium Keetberglaan Therapeutic Categories — 5 Specializations